Oncology Clinical Trial Market, Global Outlook and Forecast 2023-2029
Report Code: KNJ1551464 No. of Pages: 63 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Clinical trials are the final step in a long process that begins with research in a lab.
This report aims to provide a comprehensive presentation of the global market for Oncology Clinical Trial, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Clinical Trial. This report contains market size and forecasts of Oncology Clinical Trial in global, including the following market information:
Global Oncology Clinical Trial Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Oncology Clinical Trial market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Oncology trials are predominantly early-phase studies that evaluate surrogate end points and are small, single arm, and open label.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Clinical Trial companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Clinical Trial Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Oncology Clinical Trial Market Segment Percentages, by Type, 2022 (%)
Prostate Cancer
Lung Cancer
Breast Cancer
Leukemia
Others
Global Oncology Clinical Trial Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Oncology Clinical Trial Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Lab
Global Oncology Clinical Trial Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Oncology Clinical Trial Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Clinical Trial revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Oncology Clinical Trial revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
IQVIA
Charles River Laboratory
ICON Plc
Medelis, Inc.
Medpace Holdings, Inc.
PAREXEL International
Pharmaceutical Product Development, LLC
Pivotal
PRA Health Sciences
Syneos Health
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Clinical Trial, market overview.
Chapter 2: Global Oncology Clinical Trial market size in revenue.
Chapter 3: Detailed analysis of Oncology Clinical Trial company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Clinical Trial in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Oncology Clinical Trial Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Clinical Trial Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Clinical Trial Overall Market Size
2.1 Global Oncology Clinical Trial Market Size: 2022 VS 2029
2.2 Global Oncology Clinical Trial Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Oncology Clinical Trial Players in Global Market
3.2 Top Global Oncology Clinical Trial Companies Ranked by Revenue
3.3 Global Oncology Clinical Trial Revenue by Companies
3.4 Top 3 and Top 5 Oncology Clinical Trial Companies in Global Market, by Revenue in 2022
3.5 Global Companies Oncology Clinical Trial Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oncology Clinical Trial Players in Global Market
3.6.1 List of Global Tier 1 Oncology Clinical Trial Companies
3.6.2 List of Global Tier 2 and Tier 3 Oncology Clinical Trial Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Oncology Clinical Trial Market Size Markets, 2022 & 2029
4.1.2 Prostate Cancer
4.1.3 Lung Cancer
4.1.4 Breast Cancer
4.1.5 Leukemia
4.1.6 Others
4.2 By Type - Global Oncology Clinical Trial Revenue & Forecasts
4.2.1 By Type - Global Oncology Clinical Trial Revenue, 2018-2023
4.2.2 By Type - Global Oncology Clinical Trial Revenue, 2024-2029
4.2.3 By Type - Global Oncology Clinical Trial Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Oncology Clinical Trial Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Lab
5.2 By Application - Global Oncology Clinical Trial Revenue & Forecasts
5.2.1 By Application - Global Oncology Clinical Trial Revenue, 2018-2023
5.2.2 By Application - Global Oncology Clinical Trial Revenue, 2024-2029
5.2.3 By Application - Global Oncology Clinical Trial Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Oncology Clinical Trial Market Size, 2022 & 2029
6.2 By Region - Global Oncology Clinical Trial Revenue & Forecasts
6.2.1 By Region - Global Oncology Clinical Trial Revenue, 2018-2023
6.2.2 By Region - Global Oncology Clinical Trial Revenue, 2024-2029
6.2.3 By Region - Global Oncology Clinical Trial Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Oncology Clinical Trial Revenue, 2018-2029
6.3.2 US Oncology Clinical Trial Market Size, 2018-2029
6.3.3 Canada Oncology Clinical Trial Market Size, 2018-2029
6.3.4 Mexico Oncology Clinical Trial Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Oncology Clinical Trial Revenue, 2018-2029
6.4.2 Germany Oncology Clinical Trial Market Size, 2018-2029
6.4.3 France Oncology Clinical Trial Market Size, 2018-2029
6.4.4 U.K. Oncology Clinical Trial Market Size, 2018-2029
6.4.5 Italy Oncology Clinical Trial Market Size, 2018-2029
6.4.6 Russia Oncology Clinical Trial Market Size, 2018-2029
6.4.7 Nordic Countries Oncology Clinical Trial Market Size, 2018-2029
6.4.8 Benelux Oncology Clinical Trial Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Oncology Clinical Trial Revenue, 2018-2029
6.5.2 China Oncology Clinical Trial Market Size, 2018-2029
6.5.3 Japan Oncology Clinical Trial Market Size, 2018-2029
6.5.4 South Korea Oncology Clinical Trial Market Size, 2018-2029
6.5.5 Southeast Asia Oncology Clinical Trial Market Size, 2018-2029
6.5.6 India Oncology Clinical Trial Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Oncology Clinical Trial Revenue, 2018-2029
6.6.2 Brazil Oncology Clinical Trial Market Size, 2018-2029
6.6.3 Argentina Oncology Clinical Trial Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Oncology Clinical Trial Revenue, 2018-2029
6.7.2 Turkey Oncology Clinical Trial Market Size, 2018-2029
6.7.3 Israel Oncology Clinical Trial Market Size, 2018-2029
6.7.4 Saudi Arabia Oncology Clinical Trial Market Size, 2018-2029
6.7.5 UAE Oncology Clinical Trial Market Size, 2018-2029
7 Oncology Clinical Trial Companies Profiles
7.1 IQVIA
7.1.1 IQVIA Company Summary
7.1.2 IQVIA Business Overview
7.1.3 IQVIA Oncology Clinical Trial Major Product Offerings
7.1.4 IQVIA Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.1.5 IQVIA Key News & Latest Developments
7.2 Charles River Laboratory
7.2.1 Charles River Laboratory Company Summary
7.2.2 Charles River Laboratory Business Overview
7.2.3 Charles River Laboratory Oncology Clinical Trial Major Product Offerings
7.2.4 Charles River Laboratory Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.2.5 Charles River Laboratory Key News & Latest Developments
7.3 ICON Plc
7.3.1 ICON Plc Company Summary
7.3.2 ICON Plc Business Overview
7.3.3 ICON Plc Oncology Clinical Trial Major Product Offerings
7.3.4 ICON Plc Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.3.5 ICON Plc Key News & Latest Developments
7.4 Medelis, Inc.
7.4.1 Medelis, Inc. Company Summary
7.4.2 Medelis, Inc. Business Overview
7.4.3 Medelis, Inc. Oncology Clinical Trial Major Product Offerings
7.4.4 Medelis, Inc. Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.4.5 Medelis, Inc. Key News & Latest Developments
7.5 Medpace Holdings, Inc.
7.5.1 Medpace Holdings, Inc. Company Summary
7.5.2 Medpace Holdings, Inc. Business Overview
7.5.3 Medpace Holdings, Inc. Oncology Clinical Trial Major Product Offerings
7.5.4 Medpace Holdings, Inc. Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.5.5 Medpace Holdings, Inc. Key News & Latest Developments
7.6 PAREXEL International
7.6.1 PAREXEL International Company Summary
7.6.2 PAREXEL International Business Overview
7.6.3 PAREXEL International Oncology Clinical Trial Major Product Offerings
7.6.4 PAREXEL International Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.6.5 PAREXEL International Key News & Latest Developments
7.7 Pharmaceutical Product Development, LLC
7.7.1 Pharmaceutical Product Development, LLC Company Summary
7.7.2 Pharmaceutical Product Development, LLC Business Overview
7.7.3 Pharmaceutical Product Development, LLC Oncology Clinical Trial Major Product Offerings
7.7.4 Pharmaceutical Product Development, LLC Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.7.5 Pharmaceutical Product Development, LLC Key News & Latest Developments
7.8 Pivotal
7.8.1 Pivotal Company Summary
7.8.2 Pivotal Business Overview
7.8.3 Pivotal Oncology Clinical Trial Major Product Offerings
7.8.4 Pivotal Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.8.5 Pivotal Key News & Latest Developments
7.9 PRA Health Sciences
7.9.1 PRA Health Sciences Company Summary
7.9.2 PRA Health Sciences Business Overview
7.9.3 PRA Health Sciences Oncology Clinical Trial Major Product Offerings
7.9.4 PRA Health Sciences Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.9.5 PRA Health Sciences Key News & Latest Developments
7.10 Syneos Health
7.10.1 Syneos Health Company Summary
7.10.2 Syneos Health Business Overview
7.10.3 Syneos Health Oncology Clinical Trial Major Product Offerings
7.10.4 Syneos Health Oncology Clinical Trial Revenue in Global Market (2018-2023)
7.10.5 Syneos Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com